Opioid Use Disorder (OUD) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033


 

Opioids are chemicals that can be natural, semi-synthetic, or synthetic, and they interact with the body and brain's opioid receptors to diminish the sensation of pain. While the terms opioids and opiates are often used synonymously, opiates refer exclusively to natural substances derived from the poppy plant, like morphine or heroin. Opioids, on the other hand, can be either naturally occurring or synthetically produced in laboratories. The majority of opioids are prescribed, though a significant number are also acquired illegally. It is common for patients to develop opioid dependence after using opioids for a short time, which can present as either physical or psychological dependence, or both, leading to withdrawal symptoms if the opioid use is suddenly discontinued. Opioid use disorder (OUD) can affect individuals across all educational and socioeconomic strata. OUD is more likely in patients who lack certain neurotransmitters such as dopamine, have first-degree relatives with substance abuse disorders, or have been exposed to environments where opioid use is prevalent. Risk factors also include having peers who use opioids or exposure to opioid analgesics from past injuries. Additionally, those with untreated depression, post-traumatic stress disorder, anxiety, or a history of childhood trauma are also more susceptible to developing OUD. OUD typically progresses through a continuum of opioid use. Physical dependence can develop quickly, often due to alterations in the mu-opioid receptors, such as desensitization, internalization, and signaling abnormalities. This physical dependence is also a critical factor in the withdrawal symptoms experienced when opioid use is abruptly ceased, reinforcing both the continuation and cessation of opioid use. A diagnosis of OUD is made when an individual's ongoing use of opioids causes significant impairment or distress, which can manifest as difficulties in controlling opioid use and intense cravings for the drug. The treatment of OUD not only improves physical and psychological health but also reduces the likelihood of overdose, criminal behavior, and subsequent penalties. Treatment strategies include a variety of rehabilitation approaches that begin with cognitive behavioral techniques similar to those used for other chronic conditions. Medication-assisted treatment (MAT), including opioid replacement, maintenance, or substitution therapy under medical supervision, utilizes safer opioid alternatives. Such treatments, including outpatient buprenorphine office therapy (OBOT), help reduce withdrawal symptoms, diminish cravings, and minimize or eliminate euphoria. These therapeutic strategies are essential in managing and maintaining recovery in patients with OUD.

Thelansis’s “Opioid Use Disorder (OUD) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Opioid Use Disorder (OUD) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Opioid Use Disorder (OUD) across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Opioid Use Disorder (OUD) Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Opioid Use Disorder (OUD) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Comments

Post a Comment

Popular posts from this blog

Acne Vulgaris – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Image
  Acne vulgaris, a prevalent pilosebaceous unit inflammatory skin disorder, follows a persistent course. Typically presenting as papules, pustules, or nodules, it primarily occurs on the face but can also impact the upper arms, trunk, and back. The development of acne results from the sebaceous glands' heightened sensitivity to normal androgen levels, aggravated by Cutibacterium acnes (formerly known as Propionibacterium acnes), a bacterial species that triggers inflammation. The pathogenesis of acne vulgaris involves a complex interplay of factors such as the activation of sebaceous glands by androgens, imbalances in the pilosebaceous follicle microbiome, and cellular immune responses. Genetic predisposition and dietary influences also contribute to the condition's onset and progression. The initial stage is the micro-comedo, a small plug primarily composed of corneocytes in the lower follicular infundibulum. Microcomedones evolve into various acne lesions, including closed co...
Read more

Herpes Simplex Virus (HSV) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
 Herpes simplex virus (HSV) causes an infection that affects the external genitalia, anal region, mucosal surfaces, and skin in other body parts. Herpes simplex virus is a ubiquitous, host-adapted pathogen that causes various disease states. There are two types of HSV with two distinct DNA viruses, type 1 (HSV-1) and type 2 (HSV-2). Both the types are closely related but differ epidemiologically. HSV-1 is traditionally associated with orofacial disease by affecting the mouth and lips with fever blisters and cold sores, whereas HSV-2 is associated traditionally with genital disease infecting genitals and rectum area with sores and is classified as STD (sexually transmitted disease). As HSV-1 is associated with genital infections more often than HSV-2, lesion location is not necessarily of viral type. HSV can spread through direct contact. Almost 80% of Herpes simplex infections are asymptomatic, while symptomatic infections can be characterized by significant morbidity and recurrenc...
Read more

HR+/HER2- Breast Cancer – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
Thelansis’s “HR+/HER2- Breast Cancer Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential HR+/HER2- Breast Cancer treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). KOLs insights of HR+/HER2- Breast Cancer across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs. HR+/HER2- Breast Cancer Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model,...
Read more